Get startedLog in
    Picture of Human Metabolome Technologies logo

    6090 — Human Metabolome Technologies Income Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareBalancedMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Human Metabolome Technologies, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.

    2020
    June 30th
    2021
    June 30th
    2022
    June 30th
    2023
    June 30th
    2024
    June 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,1181,1241,2231,2991,346
    Cost of Revenue
    Gross Profit857806840860869
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses1,1441,0941,0231,0841,105
    Operating Profit-25.130200215241
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-24.550.9262237262
    Provision for Income Taxes
    Net Income After Taxes-47.858.2268286243
    Net Income Before Extraordinary Items
    Net Income-47.858.2268286243
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-47.858.2268286243
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-7.2610.844.447.937.9
    Dividends per Share